XTL Biopharmaceutica Stock Forecast - Period Momentum Indicator
| XTLB Stock | USD 1.88 0.05 2.73% |
XTL Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast XTL Biopharmaceutica stock prices and determine the direction of XTL Biopharmaceuticals Ltd's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of XTL Biopharmaceutica's historical fundamentals, such as revenue growth or operating cash flow patterns.
XTL |
| Check XTL Biopharmaceutica Volatility | Backtest XTL Biopharmaceutica | Information Ratio |
XTL Biopharmaceutica Trading Date Momentum
| On November 25 2024 XTL Biopharmaceuticals Ltd was traded for 1.88 at the closing time. The top price for the day was 1.88 and the lowest listed price was 1.69 . There was no trading activity during the period 0.0. Lack of trading volume on November 25, 2024 had no short-term effect on price fluctuation. The trading price change against the current closing price is 6.91% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
| Compare XTL Biopharmaceutica to competition |
Other Forecasting Options for XTL Biopharmaceutica
For every potential investor in XTL, whether a beginner or expert, XTL Biopharmaceutica's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. XTL Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in XTL. Basic forecasting techniques help filter out the noise by identifying XTL Biopharmaceutica's price trends.XTL Biopharmaceutica Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with XTL Biopharmaceutica stock to make a market-neutral strategy. Peer analysis of XTL Biopharmaceutica could also be used in its relative valuation, which is a method of valuing XTL Biopharmaceutica by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
XTL Biopharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of XTL Biopharmaceutica's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of XTL Biopharmaceutica's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
XTL Biopharmaceutica Market Strength Events
Market strength indicators help investors to evaluate how XTL Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XTL Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying XTL Biopharmaceutica stock market strength indicators, traders can identify XTL Biopharmaceuticals Ltd entry and exit signals to maximize returns.
XTL Biopharmaceutica Risk Indicators
The analysis of XTL Biopharmaceutica's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in XTL Biopharmaceutica's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting xtl stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.0 | |||
| Standard Deviation | 6.75 | |||
| Variance | 45.53 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether XTL Biopharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of XTL Biopharmaceutica's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xtl Biopharmaceuticals Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xtl Biopharmaceuticals Ltd Stock:Check out Historical Fundamental Analysis of XTL Biopharmaceutica to cross-verify your projections. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XTL Biopharmaceutica. If investors know XTL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XTL Biopharmaceutica listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.76) | Earnings Share (0.03) | Return On Assets (0.14) | Return On Equity (0.13) |
The market value of XTL Biopharmaceuticals is measured differently than its book value, which is the value of XTL that is recorded on the company's balance sheet. Investors also form their own opinion of XTL Biopharmaceutica's value that differs from its market value or its book value, called intrinsic value, which is XTL Biopharmaceutica's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XTL Biopharmaceutica's market value can be influenced by many factors that don't directly affect XTL Biopharmaceutica's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XTL Biopharmaceutica's value and its price as these two are different measures arrived at by different means. Investors typically determine if XTL Biopharmaceutica is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XTL Biopharmaceutica's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.